The Influencing Factors of 12 Week Efficacy of Polyethylene Glycol Losenatide in Type 2 Diabetes Patients
Status:
Recruiting
Trial end date:
2025-12-31
Target enrollment:
Participant gender:
Summary
The effect of polyethylene glycol Losenatide on body fat, insulin resistance, weight, blood
sugar, blood lipid, stomach volume and other factors in patients with type 2 diabetes through
12 week follow-up, and explore the factors affecting the efficacy, so as to provide more
evidence-based medical basis for drug treatment and benefit patients.
Phase:
Phase 4
Details
Lead Sponsor:
Nanjing First Hospital, Nanjing Medical University